4//SEC Filing
Cellectar Biosciences, Inc. 4
Accession 0001144204-16-095611
$CLRBCIK 0001279704operating
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 6:03 PM ET
Size
7.9 KB
Accession
0001144204-16-095611
Insider Transaction Report
Form 4
NEIS JOHN
Director
Transactions
- Purchase
Common Stock, par value $0.00001 per share
2016-04-20$2.12/sh+234,742$497,653→ 297,984 total(indirect: See Footnote) - Purchase
Series A Warrants
2016-04-20$0.01/sh+234,742$2,347→ 274,613 total(indirect: See Footnote)Exercise: $3.04From: 2016-04-20Exp: 2021-04-20→ Common Stock (234,742 underlying)
Footnotes (1)
- [F1]These securities are held by Venture Investors Early Stage fund IV Limited Partnership and Advantage Capital Wisconsin Partners I, Limited Partnership. VIESF IV GP LLC is the general partner of Venture Investors Early Stage Fund IV Limited Partnership and Venture Investors LLC is the submanager and special limited partner of Advantage Capital Wisconsin Partners I, Limited Partnership. The investment decisions of VIESF IV GP LLC and Venture Investors LLC are made collectively by seven managers, including the reporting person. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest herein.
Documents
Issuer
Cellectar Biosciences, Inc.
CIK 0001279704
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001279704
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 6:03 PM ET
- Size
- 7.9 KB